Low FOXE1 expression in parallel with promoter hypermethylation was observed in colorectal, salivary gland, skin, and other types of cancer (14–17), and it was proposed that methylation of FOXE1 could be a promising marker for cancer detection (18, 19). The gene discussed is FOXE1; the disease is cancer.